Introduction
Exposure to polycyclic aromatic hydrocarbons is an important cause of cancer because these molecules are activated by selected enzymes, including P-450s and cyclooxygenase (COX) to carcinogenic metabolites. For example, benzo[a]-pyrene (B[a]P), a component of tobacco smoke, undergoes metabolic biotransformation to electrophilic intermediates that react with cellular DNA and protein. The extent to which a given exposure to carcinogens produces adducts between reactive metabolites and cellular components in vivo depends on the balance between rates of oxidation of the parent compound and rates of detoxification of reactive metabolites via conjugation (1) . Thus, induction of mono-oxygenase enzymes (2) or inhibition of conjugating enzymes (1, 3) enhances the covalent binding of B[a]P metabolites to DNA.
The cytochrome P-450 family of enzymes including CYP1A1 and CYP1B1 is widely recognized for catalyzing oxidative reactions and activating xenobiotics to reactive metabolites that are carcinogenic (4EE6). COX is capable of co-oxidizing B[a]P; the peroxyl radicals formed during arachidonic acid metabolism catalyze the epoxidation of B[a]P to its mutagenic products (7, 8) . In this regard, COX-2, an inducible form of COX, may be particularly important because it is frequently over-expressed in intraepithelial neoplasia of the aerodigestive tract (9, 10) . Previous studies have suggested a role for each of these enzymes in carcinogenesis of the upper aerodigestive tract (11EE13).
The UDP-glucuronosyltransferases (UGTs) are a large multigene family of phase 2 enzymes that catalyze the detoxification of many xenobiotics and their metabolic intermediates. Several studies have demonstrated that UGTs protect against the carcinogenic effects of tobacco smoke and B[a]P. The addition of UDP-glucuronic acid to the Ames test is associated with a reduction of B[a]P-induced mutagenicity (14) . Reduced glucuronidation of B[a]P metabolites correlated with increased covalent binding to hepatic DNA and microsomal protein in UGT-deficient rats (15) . Importantly, this concept has been extended to humans. Several human UGTs detoxify B[a]P metabolites including 3-hydroxy-benzo[a]pyrene (3-OH-B[a]P), 7-hydroxy-benzo[a]pyrene (7-OH-B[a]P), 9-hydroxy-benzo[a]pyrene (9-OH-B[a]P) (16EE19). In studies examining polymorphisms in the UGT1A7 gene, three allelic variants of wild-type UGT1A7 were identified (16, 20) . The enzymes encoded by the three variant alleles are less active in glucuronidating B[a]P phenols than the wild-type enzyme (16) . Individuals with any of the predicted low-activity UGT1A7 genotypes were found to be at markedly increased risk of developing smoking-related orolaryngeal cancer (20) . Similarly, Elahi and colleagues have shown recently that a non-conservative missense polymorphism in codon 139 of the UGT1A10 gene is associated with risk for orolaryngeal cancer (21) . Although the precise mechanism linking lowactivity UGT1A7 or UGT1A10 to tobacco smoke-induced cancer is uncertain, reduced glucuronidation may result in increased levels of B[a]P phenols in target tissues. If B[a]P phenols like other aryl hydrocarbons induce CYP1A1, CYP1B1 and COX-2 (22EE24), this would be predicted to increase the risk of tobacco smoke-induced carcinogenesis.
This study was designed to explore the effects of B[a]P phenols on levels of carcinogen-activating enzymes in cell lines derived from the human aerodigestive tract. We show that hydroxylated metabolites of B[a]P induce CYP1A1, CYP1B1 and COX-2. In contrast, the corresponding glucuronide conjugates of B[a]P caused less induction of each of these enzymes. Taken together, these results may help to explain why individuals with low-activity UGT genotypes are at increased risk for tobacco smoke-related orolaryngeal cancer.
Materials and methods

Materials
Keratinocyte growth media (KGM) was obtained from Clonetics (San Diego, CA). DMEM and FBS were from Life Technologies (Grand Island, NY). Enzyme immunoassay reagents for assays of prostaglandin E 2 (PGE 2 ) were from Cayman (Ann Arbor, MI). Nitrocellulose membranes were from Schleicher & Schuell (Keene, NH). DNA and RNA were prepared using kits from Qiagen (Chatsworth, CA). The 18S rRNA cDNA was from Ambion (Austin, TX). [a- 32 Cell culture MSK-Leuk1 cells were established from a dysplastic leukoplakia lesion adjacent to a squamous cell carcinoma of the tongue (26) . Cells were routinely maintained in KGM, grown to 60% confluency and trypsinized with 0.125% trypsinEE2 mM EDTA solution. Treatments were carried out using basal medium. The 1483 head and neck squamous carcinoma cell line (27) was grown in a 1:1 mixture of DMEM/F12 supplemented with 10% FBS, 50 mg/ml gentamicin and 0.25 mg/ml amphotericin. The H2122 cell line, a non-small cell lung cancer cell line harboring oncogenic mutations in Ras (28) , was a generous gift of Dr Raphael A.Nemenoff (University of Colorado, Denver, CO). H2122 cells were maintained in DMEM supplemented with 10% fetal bovine serum, 100 IU/ml penicillin and 100 mg/ml streptomycin. All cell lines were grown in basal medium for 24 h before treatment.
For uptake studies, cell culture was performed as described above using
C. Cells were subsequently washed six times in phosphate-buffered saline, with cells counted prior to the last wash, and re-suspended as a cell lysate in 1 ml Tris-buffered saline (pH 7.4; 2.5 mM Tris-base, 13.8 mM NaCl, 0.27 mM KCl). The entire cell suspension was directly counted for radioactive incorporation of substrate by scintillation counting. PGE 2 production 2.5 Â 10 5 cells/well were plated in 6-well dishes. The levels of PGE 2 released by cells were measured by enzyme immunoassay. Production of PGE 2 was normalized to protein concentrations.
Western blotting
Cell lysates were prepared by treating cells with lysis buffer consisting of 150 mM NaCl, 100 mM Tris-buffered saline (pH 8.0), 1% Tween-20, 50 mM diethyldithiocarbamate, 1 mM EDTA and 1 mM phenylmethylsulfonyl fluoride. Lysates were sonicated for 20 s on ice and centrifuged at 10 000 g for 10 min to sediment the particulate material. The protein concentration was measured by the method of Lowry et al. (29) . Sodium dodecyl sulfate (SDS)EE polyacrylamide gel electrophoresis was performed under reducing conditions on 10% polyacrylamide gels as described by Laemmli (30) . The resolved proteins were transferred onto nitrocellulose sheets as detailed by Towbin et al. (31) . The nitrocellulose membrane was then incubated with primary antisera. Secondary antibody to IgG conjugated to horseradish peroxidase was then used. The proteins were then detected by incubation with ECL reagents according to the manufacturer's instructions. The results shown are representative of individual experiments carried out a minimum of three times.
Northern blotting
Total cellular RNA was isolated from cell monolayers using an RNA isolation kit from Qiagen. Ten micrograms of total RNA per lane were electrophoresed in a formaldehyde-containing 1.2% agarose gel and transferred to nylonsupported membranes. After baking, membranes were pre-hybridized for 4 h and then hybridized in a solution containing 50% formamide, 5Â sodium chloride-sodium phosphate-EDTA buffer (SSPE), 5Â Denhardt's solution, 0.1% SDS and 100 mg/ml single-stranded salmon sperm DNA. Hybridization was carried out for 16 h at 42 C with radiolabeled cDNA probes for human COX-2 (a gift from Dr Stephen M.Prescott, University of Utah, Salt Lake City, UT) or human CYP1A1 (Oxford Biomedical Research, Oxford, MI). To verify equivalency of RNA loading in the different lanes, the blot was stripped of radioactivity and re-hybridized to determine levels of 18S rRNA. COX-2, CYP1A1 and 18S rRNA probes were labeled with [ 32 P]dCTP by random priming. After hybridization, membranes were washed twice for 20 min at room temperature in 2Â SSPEEE0.1% SDS, and twice for 20 min in 0.1Â SSPEEE0.1% SDS at room temperature. Washed membranes were then subjected to autoradiography.
Plasmids
The XRE luciferase plasmid pGudLuc6.1 was a kind gift of Dr Michael S.Denison from the University of California at Davis (Davis, CA). The dominant negative Ah receptor (AhR) construct pEF-hAhR-L678A was a gift of Dr Gary H.Perdew from Pennsylvania State University (University Park, PA) (32) . pSVbgal was obtained from Promega (Madison, WI).
Transient transfection assays MSK-Leuk1 cells were seeded at a density of 8 Â 10 5 cells/well in 6-well dishes and grown to 60% confluence. For each well, 2 mg of plasmid DNA were introduced using LipoFECTAMINE 2000 as per the manufacturer's instructions. After 4 h of incubation, the medium was replaced with basal medium. The activities of luciferase and b-galactosidase were measured in cellular extracts as described previously (33) .
Patient samples
Specimens were obtained from six healthy non-smoking human volunteers. The buccal mucosa was examined and then anaesthetized with topical cetacaine spray. A 3 mm punch was used to biopsy the mucosa and the specimen was immediately snap frozen and stored at À80 C. The study was approved by the Committee on Human Rights in Research of Weill Medical College of Cornell University.
Analysis of CYP1B1 expression
Total cellular RNA was isolated from frozen buccal mucosa specimens using the RNeasy Mini-kit with on-column DNA digestion using RNase-free DNase according to the manufacturer's instructions. Reverse transcription was performed using 1 mg RNA per 50 ml reaction. The reaction mixture contained 1Â PCR Buffer II, MgCl 2 2.5 mM, dNTP (250 mM each), RNAse inhibitor (1 U/ml), MuLV reverse transcriptase (2.5 U/ml) and random hexamers (2.5 mM). Samples were incubated for 10 min at room temperature, then cycled at 42 C for 15 min and 95 C for 10 min. CYP1B1 expression was then determined by RTEEPCR. Two microliters of cDNA was subjected to 30 cycles of PCR in a 25 ml reaction mixture (1Â PCR Buffer II, 2 mM MgCl 2 , 400 mM dNTPs, Taq polymerase 2.5 U and upstream and downstream primers). Primers used were: CYP1B1 forward 5 C for 10 min. The PCR product was electrophoresed through 1% agarose with ethidium bromide in 1Â TBE, and photographed under UV light. The identity of the CYP1B1 PCR product was confirmed by direct sequencing.
Statistics
Comparisons were made by the Student's t-test. A difference between groups of P 5 0.05 was considered significant. Recently, CYP1B1 has been postulated to be important in the pathogenesis of head and neck cancer (34) . As a first step in evaluating this question, we determined whether CYP1B1 was expressed in human buccal mucosa. RTEEPCR revealed CYP1B1 expression in buccal biopsy samples from each of six healthy non-smoking volunteers (Figure 2A ). Based on this finding, it was relevant to determine the effects of B[a]P phenols and B[a]P glucuronides on cellular levels of CYP1B1. In comparison with B[a]P glucuronides, B[a]P and its hydroxylated metabolites caused marked induction of CYP1B1 in cell lines (MSK-Leuk, H2122) derived from the oral cavity ( Figure 2B ) and lung ( Figure 2C ).
Results
We investigated whether B[a]P or its hydroxylated metabolites (3-OH-B[a]P, 7-OH-B[a]P, 9-OH-B[a]P) induced
Aryl hydrocarbons stimulate the transcription of both CYP1A1 and CYP1B1 by a mechanism that involves binding of ligand-activated AhR to a xenobiotic responsive element in the promoters of these genes (4, 23) . Consistent with this concept, B[a]P-mediated activation of XRE-luciferase was abrogated by over-expressing a dominant negative form of AhR in oral epithelial cells ( Figure 3A) . Each of the hydroyxlated metabolites of B[a]P was a more potent inducer of XRE-luciferase activity than the corresponding glucuronide ( Figure 3B ).
In addition to being able to induce CYP1A1 and CYP1B1, B[a]P has been reported to stimulate COX-2 transcription and the synthesis of PGE 2 (24) . It was of considerable interest, therefore, to compare the effects of B[a]P phenols and B[a]P glucuronides on prostaglandin (PG) biosynthesis. As shown in Figure 4 , B[a]P phenols were more potent inducers of PG production than B[a]P glucuronides. Western blotting was subsequently carried out to evaluate whether B[a]P phenolmediated induction of PG synthesis reflected enhanced COX-2 expression. B[a]P and its phenols induced COX-2 protein in cell lines derived from both the head and neck and lung ( Figure 5 ). Analysis of COX-2 expression in the H2122 cell line demonstrated that this induction was dosedependent for B[a]P as well as its hydroxylated metabolites ( Figure 5C ). Northern blot analysis demonstrated that COX-2 mRNA was also induced by treatment with B[a]P and its hydroxylated metabolites ( Figure 5D ). As was the case for CYP1A1 and CYP1B1, each of the B[a]P phenols was a more potent inducer of COX-2 than the corresponding glucuronide ( Figure 6 ).
Differences in uptake of the conjugated versus unconjugated B[a]P hydroxylated metabolites into cells might explain why B[a]P glucuronides caused less induction of CYP1A1, CYP1B1 and COX-2 than B[a]P phenols. As shown in Table I , there were minimal differences in the uptake of B[a]P-3-O-G compared with its unconjugated 3-OH-B[a]P counterpart in the 1483 cell line. In contrast, a large difference in uptake 
Discussion
Several UGTs including UGT1A7 and UGT1A10 are expressed in aerodigestive tract tissues (20, 35EE37) and were shown to detoxify tobacco smoke carcinogens (16, 25) . Recent studies have implicated UGT genetic variants in risk for aerodigestive tract cancers. Zheng and colleagues have reported that individuals with any of the predicted low-activity UGT1A7 genotypes who smoked had an increased risk of orolaryngeal cancer compared with those subjects with the wild-type genotype (20) . In contrast, there was no association between UGT1A7 genotype and risk of development of orolaryngeal cancer in never smokers (20) . A link between polymorphisms of UGT1A7 and cancers of the proximal digestive tract (36), colon (38) and liver (39) has also been reported. Similarly, Elahi and colleagues have found recently that a nonconservative missense polymorphism in codon 139 of the UGT1A10 gene is associated with risk for orolaryngeal cancer (21) . Together, these studies implicate glucuronidation as an important pathway for tobacco smoke carcinogen detoxification in the aerodigestive tract.
The primary purpose of the current study was to investigate the mechanistic basis for the increased risk of orolaryngeal cancer associated with variant UGT genotypes. B[a]P phenols, which comprise a major form of B[a]P metabolites, are among the B[a]P metabolites that are glucuronidated by UGTs 1A7 and 1A10 (16, 18, 19) . Glucuronides undergo biliary or renal elimination. It seems likely, therefore, that the levels of B[a]P metabolites will increase in the mucosa of individuals with low-activity UGT genotypes who smoke tobacco. If B[a]P metabolites such as B[a]P phenols induce carcinogenactivating enzymes, this would be predicted, in turn, to increase the risk of cancer.
CYP1A1, CYP1B1 and COX-2 convert tobacco carcinogens to reactive metabolites that form DNA adducts. Previous studies have demonstrated the expression of both CYP1A1 and COX-2 in the oral cavity (13, 40) . To the best of our knowledge, the present study is the first to show that CYP1B1 is also expressed in oral mucosa.
Each of the B[a]P phenols examined in this study induced CYP1A1, CYP1B1 and COX-2 in cell lines derived from the human aerodigestive tract including the oral cavity. Importantly, B[a]P glucuronides caused less induction of each of these enzymes. We considered the possibility that differences in cellular uptake of B[a]P phenols versus the corresponding glucuronide conjugate could explain the observed differences in enzyme induction. For MSK-Leuk1 cells, differential uptake of 3-OH-B[a]P and its glucuronide conjugate may explain at least, in part, the finding that B[a]P phenols were more potent inducers of xenobiotic metabolizing enzymes than B[a]P glucuronides. In contrast, no difference in uptake between the two compounds was observed in 1483 cells, suggesting that glucuronide conjugate formation can induce a protective effect by directly altering B[a]P metabolite-induced activities within a cell. Differences in binding to the AhR could potentially explain why B[a]P phenols are more potent inducers of xenobiotic metabolizing enzymes than B[a]P glucuronides. Regardless of the underlying mechanism, these findings are potentially important for understanding the link between reduced glucuronidation and tobacco smoke-induced orolaryngeal cancer. In individuals with low-activity UGT genotypes who smoke tobacco, B[a]P phenol-mediated induction of xenobiotic metabolizing enzymes should amplify the effect of a given dose of B[a]P on tumor initiation. An important next step will be to determine whether levels of CYP1A1, CYP1B1 and COX-2 are higher than normal in the buccal mucosa of smokers with low-activity UGT genotypes.
In addition to potentially increasing the activation of carcinogens, B[a]P phenol-mediated induction of COX-2 could predispose to carcinogenesis by other mechanisms. Enhanced synthesis of COX-2-derived PGs favors tumor growth by stimulating cell proliferation (41), promoting angiogenesis (42, 43) , increasing invasiveness (44, 45) and inhibiting apoptosis (46, 47) . Therefore, selective COX-2 inhibitors may have a role in protecting against tobacco smoke-induced carcinogenesis in individuals with lowactivity UGT genotypes.
In summary, our study provides a mechanism for the increased risk of orolaryngeal cancer in smokers with lowactivity UGT genotypes. We have demonstrated that B[a]P phenols are more potent inducers of CYP1A1, CYP1B1 and COX-2 than the corresponding B[a]P glucuronides. These results support the concept of developing chemopreventive agents that induce UGTs such as UGT1A7 and UGT1A10. T.Almahmeed et al.
